Geriatrics
Phenotypes and subphenotypes of delirium: a review of current categorizations and suggestions for progression.
23 Sep, 2021 | 09:54h | UTC
Palliative and End-of-Life Care: Prioritizing Compassion Within the ICU and Beyond.
22 Sep, 2021 | 09:57h | UTC
Cluster RCT: Implementing C reactive protein point-of-care testing in nursing homes may reduce antibiotic prescribing for suspected lower respiratory tract infections.
22 Sep, 2021 | 10:02h | UTC
AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee.
21 Sep, 2021 | 09:03h | UTCNews release: AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee – American Academy of Orthopaedic Surgeons
Guideline summary: Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition) – American Academy of Orthopaedic Surgeons
Full paper: Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline
An FDA panel says only high-risk Americans and those 65+ should get covid boosters.
19 Sep, 2021 | 23:45h | UTCAn FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR
See also:
5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN
Top doctors say not so fast to Biden’s boosters-for-all plan – Associated Press
Related:
Third shot: UK to offer COVID booster jabs to over 50s.
COVID-19 vaccine efficacy does not support boosters for general population, review concludes.
COVID vaccine effects wane over time but still prevent death and severe illness.
What’s the evidence for COVID-19 booster shots?
AAN Position Statement: Ethical Considerations in Dementia Diagnosis and Care.
17 Sep, 2021 | 10:04h | UTCEthical Considerations in Dementia Diagnosis and Care: AAN Position Statement – Neurology
An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.
16 Sep, 2021 | 10:13h | UTCProtection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine
Viewpoint | The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
14 Sep, 2021 | 08:47h | UTC
‘Do not resuscitate’ decision recorded for only 1 in 5 very sick hospitalized older patients, study finds
14 Sep, 2021 | 08:40h | UTCOriginal study: Do not attempt cardiopulmonary resuscitation (DNACPR) decisions for older medical inpatients: a cohort study – BMJ Supportive & Palliative Care
Risk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions.
12 Sep, 2021 | 22:03h | UTCRisk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions – CNN
Original study: Hospitalisation among vaccine breakthrough COVID-19 infections – The Lancet Infectious Diseases
News release: Study examines severe breakthrough cases of COVID-19 – YaleNews
Commentary on Twitter
New Comment: Hospitalisation among vaccine breakthrough #COVID19 infections https://t.co/1MtOoO8HVV, by Prerak V Juthani, @hyungjchun, and colleagues pic.twitter.com/mYAAEzHLDL
— The Lancet Infectious Diseases (@TheLancetInfDis) September 8, 2021
People with Parkinson’s may benefit from seven walking strategies.
12 Sep, 2021 | 21:40h | UTCNews release: People with Parkinson’s may benefit from seven walking strategies – American Academy of Neurology
Original study: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease – Neurology
Commentary: Compensation Strategies Benefit Parkinson Patients With Gait Impairment – HealthDay
Commentary on Twitter (thread – click for more)
In this paper, which was published today in @GreenJournal, we studied the use of compensation strategies for gait impairments in people with Parkinson’s disease. To this aim, we conducted a survey in 4.324 people with PD. https://t.co/Bn4Tn5sYEO
1/4— Jorik Nonnekes (@NonnekesJorik) September 9, 2021
Editorial | Anticholinergic drugs and dementia: time for transparency in the face of uncertainty.
9 Sep, 2021 | 08:57h | UTCSystematic review: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library
Commentary on Twitter
Anticholinergic drugs may double the risk of developing dementia. What should we be doing right now?
Editorial with @JenMStevenson for @CochraneLibrary published todayhttps://t.co/808wSGPUtm— Henry Woodford (@woodford_henry) September 8, 2021
Perspective | Rethinking medication adherence.
9 Sep, 2021 | 08:55h | UTCRethinking Medication Adherence – Therapeutics Initiative
Medical, ethical, and legal aspects of end-of-life dilemmas in the intensive care unit.
7 Sep, 2021 | 10:37h | UTC
Tube feeding for people with severe dementia: making decisions.
7 Sep, 2021 | 10:39h | UTCTube feeding for people with severe dementia: making decisions – Evidently Cochrane
Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study.
6 Sep, 2021 | 10:36h | UTCDifferentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentary: Can We Detect Central Vertigo on Exam? – Journal Feed
Review: Cardiovascular care of older adults.
3 Sep, 2021 | 10:13h | UTCCardiovascular care of older adults – The BMJ
Musculoskeletal complications following critical illness: A scoping review.
3 Sep, 2021 | 10:07h | UTC
Commentary on Twitter
Very pleased that our scoping review on MSK complications following critical illness has been published – first paper from my PhD! @mawilliamsinOx @helendawes2 @matthewjrowland @ouh_therapies @MOReS_OBU #icurehab https://t.co/f6kHDtMzrj pic.twitter.com/bOm3YvLP5U
— Owen Gustafson (@OxfordICUPhysio) August 26, 2021
Position Paper: Diagnosis and management of heart failure in elderly patients from hospital admission to discharge.
3 Sep, 2021 | 10:11h | UTC
NICE Guideline: Assessment and management of chronic kidney disease.
1 Sep, 2021 | 09:47h | UTC
Study shows that current definitions of chronic kidney disease overestimate the CKD burden in older individuals and results in overdiagnosis.
1 Sep, 2021 | 09:43h | UTCAccounting for Age in the Definition of Chronic Kidney Disease – JAMA Internal Medicine (free for a limited period)
Invited commentary: Overdiagnosis of Chronic Kidney Disease in Older Adults—An Inconvenient Truth – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
Should the definition of chronic kidney disease be changed to consider the physiological eGFR decline that is associated with ageing?
A new publication says yes!
To learn more visit: https://t.co/BfVrSGQ9fv pic.twitter.com/3Dpd8MDJDr
— Chronic Disease Care (@ICDC_Research) August 31, 2021
#ESCCongress – RCT: In older patients with hypertension, intensive treatment with a SBP target of 110 to less than 130 mm Hg resulted in a lower incidence of cardiovascular events than standard treatment with a target of 130 to less than 150 mm Hg.
31 Aug, 2021 | 08:49h | UTCTrial of Intensive Blood-Pressure Control in Older Patients with Hypertension – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Commentary on Twitter
Findings from STEP trial found aggressive BP management (SBP goal of 110-130 mm Hg) improved CV outcomes w/out increasing adverse events in older Chinese patients w/ #hypertension; also highlighted benefit of home BP monitoring: https://t.co/tg4hkyHvJW #ESCCongress #ACCIntl pic.twitter.com/xsO6EcC8Yi
— American College of Cardiology (@ACCinTouch) August 30, 2021
New CDC Guidance says influenza and Covid vaccines can be given together – “COVID-19 vaccines and other vaccines may now be administered without regard to timing”
29 Aug, 2021 | 18:51h | UTCCommentary: Flu shot and a COVID jab? New 2021-2022 flu vaccine guidance points to both – McKnight’s
#ESCCongress – RCT: SGLT2 inhibition reduced the combined risk of cardiovascular death or hospitalization in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.
29 Aug, 2021 | 18:19h | UTCEmpagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine
News release: Trial reports first successful results for heart failure with preserved ejection fraction – European Society of Cardiology
Commentary on Twitter
#FIGARO-DKD #ESCCongress
🔺in patients w T2D & microalbuminuria & stage 1-4 CKD, finerenone vs placebo led to 13% relative ⬇️in CV events (mostly due to 29%⬇️in HF hospitalizations)
🔺~2/3 pts +microalbuminuria w normal GFR:🔑 is to✔️in T2D#ESCCongress https://t.co/8oT5s8KjT0 pic.twitter.com/fQbmUzPasD— Ritu Thamman MD (@iamritu) August 28, 2021
#ESCCongress – RCT: Small benefit from systematic screening for atrial fibrillation in older adults – After a median follow-up of 6.9 y there were fewer events (stroke, embolism, bleeding, and death) in the intervention group (31·9%) vs. control group (33·0%).
29 Aug, 2021 | 18:08h | UTCClinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial – The Lancet (link to abstract – $ for full-text)
News release: Screening for atrial fibrillation could reduce risk of stroke – Karolinska Institutet